Showing 61-70 of 307 results for "".
Valeant Acquires Salix; Actavis Changing Name
https://practicaldermatology.com/series/dermwire-tv/valeant-acquires-salix-actavis-changing-name/18963/Valeant expands its portfolio with the acquisition of GI market leader Salix. Actavis divests Doryx and considers a name change to Allergan. Kythera acquires rights for investigational hair therapies. And Cynosure's 532nm laser delivery system is FDA cleared for PicoSure.Social Media as a Force for Good: How to Think Like a B Corp
https://practicaldermatology.com/topics/practice-management/social-media-as-a-force-for-good-how-to-think-like-a-b-corp/24009/For dermatologists, social media networks are underutilized when marketing their practices—create quality and trusted material, deliver practice-specific messaging strategies, and convey and sustain reliable information.The Game of Drones
https://practicaldermatology.com/topics/practice-management/the-game-of-drones-1/23022/Will the fledgling commercial drone delivery industry win or die? And does it matter to medicine?Physician Spotlight: Dendy Engelman, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-dendy-engelman-md/20338/Today's minimally invasive procedures deliver big results. A specialist discusses what's possible.The Future of Telemedicine in Aesthetics
https://practicaldermatology.com/topics/practice-management/the-future-of-telemedicine-in-aesthetics/21073/What are promises and pitfalls of remote medical consultation and care delivery in aesthetics?Health Disparities and Skin Cancer In People of Color
https://practicaldermatology.com/topics/skin-of-color/health-disparities-and-skin-cancer-in-people-of-color/22986/Skin cancer diagnosis and treatment may be delayed in people of color, contributing to poor prognosis.The Whole Experience: 10 Tips for Increasing Surgical Conversion Rates
https://practicaldermatology.com/topics/practice-management/the-whole-experience-10-tips-for-increasing-surgical-conversion-rates/20573/How to develop practice-wide systems and processes to help deliver a unique and patient-centric experience to up conversion from consult to procedure.Chronic Hand Eczema Treatment Landscape
https://practicaldermatology.com/series/c-suite-chats/chronic-hand-eczema-treatment-landscape/29126/Jacob Thyssen, MD, PhD, Chief Scientific Officer at Leo Pharma, talks about the incidence of chronic hand eczema and the advantage that delgocitinib provides compared to other treatment options.The Science Driving Topicals Into the Future
https://practicaldermatology.com/topics/psoriasis/the-science-driving-topicals-into-the-future/19721/On the therapeutic front, one topic Neal Bhatia, MD is paying particularly close attention to is recent advances in vehicle science, which offer novel and intriguing strategies to improve delivery of topical applications to and through the skin.Cosmeceuticals: It's All About End Results
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmeceuticals-it-s-all-about-end-results/18582/End results separate the science from the marketing of topical cosmetic products, says Annie Chiu, MD. She talks about the challenges of formulating and preserving delicate ingredients and explains why packaging is so important. Patients need education about ingredients and packaging, she says, to o